ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
88.15
-0.90 (-1.01%)
At close: Oct 9, 2026, 4:00 PM EDT
87.59
-0.56 (-0.64%)
After-hours: Oct 9, 2026, 7:59 PM EDT
ABIVAX Société Anonyme Revenue
ABIVAX Société Anonyme had revenue of 1.20M EUR in the quarter ending June 30, 2026, with 9.88% growth. This brings the company's revenue in the last twelve months to 5.03M, down -34.88% year-over-year. In the year 2025, ABIVAX Société Anonyme had annual revenue of 4.57M, down -63.29%.
Revenue (ttm)
5.03M EUR
Revenue Growth
-34.88%
P/S Ratio
1,445.96
Revenue / Employee
51,306 EUR
Employees
98
Market Cap
7.71B USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.57M | -7.88M | -63.29% |
| Dec 31, 2024 | 12.45M | 7.83M | 169.40% |
| Dec 31, 2023 | 4.62M | 38.00K | 0.83% |
| Dec 31, 2022 | 4.58M | -7.38M | -61.68% |
| Dec 31, 2021 | 11.96M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2016 | 151.00K | -77.00K | -33.77% |
| Dec 31, 2015 | 228.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Caris Life Sciences | 989.61M |
| Ionis Pharmaceuticals | 874.09M |
| TG Therapeutics | 799.54M |
| Axsome Therapeutics | 776.57M |
| Arrowhead Pharmaceuticals | 669.50M |
| Iovance Biotherapeutics | 324.97M |
| Protagonist Therapeutics | 281.99M |
| Kymera Therapeutics | 105.00M |
ABVX News
- 18 days ago - Abivax price target lowered to $118 from $140 at Wedbush - TheFly
- 18 days ago - Abivax price target lowered to $151 from $155 at Truist - TheFly
- 19 days ago - Abivax appoints Chris Rabbat as Chief Medical Officer - TheFly
- 19 days ago - Abivax Presents Business Updates and First Half 2026 Financial Results - GlobeNewsWire
- 19 days ago - ABIVAX Société Anonyme Earnings release: Q2 2026 - Filings
- 19 days ago - ABIVAX Société Anonyme Quarterly report: Q2 2026 - Filings
- 22 days ago - Will Abivax Stock (ABVX) Rise or Fall After Q2 Earnings? - TipRanks
- 4 weeks ago - Earnings To Watch: Abivax SA (XPAR:ABVX) Reports Q2 2026 Result - GuruFocus